Abstract
Aims
The aims of the study were to investigate weight loss and glycemic control parameters after different bariatric surgical procedures in type 2 diabetes (T2D) obese patients and identify patients’ factors that predict diabetes remission.
Methods
The study included 105 obese T2D patients (66 women and 39 men) who underwent laparoscopic gastric banding (LAGB, 11 subjects, age 47 ± 10 years, BMI 42.3 ± 8.3 kg/m2), or laparoscopic Roux-en-Y gastric bypass (RYBP, 77 subjects, age 50 ± 8 years, BMI 45.7 ± 6.8 kg/m2), or sleeve gastrectomy (SG, 17 subjects, age 49 ± 11 years, BMI 50.2 ± 8.8 kg/m2) during 2005–2012 period.
Results
The average percentage of weight loss at 12 months after surgery was 26.4 ± 9.8 %, and it was maintained at 24 and 36 months of follow-up. Diabetes remission occurred in 68.6 % of study participants (4/11 of LAGB, 54/77 of RYBP and 14/17 of SG). In multivariate Cox analysis, age, duration of diabetes, surgical procedure and glycated hemoglobin <53 mmol/mol (7 %) resulted significant predictors of diabetes remission (age RR = 0.97, 95 %CI 0.94–1.0, p = 0.05; diabetes duration RR = 0.93, 95 % CI 0.86–0.99, p = 0.036; rif LAGB, RYBP RR = 3.9, 95 % CI 1.31–11.57, p = 0.014; SG RR = 5.6, 95 % CI 1.67–18.64, p = 0.005; glycated hemoglobin RR = 0.54, 95 % CI 0.32–0.92, p = 0.024).
Conclusions
Bariatric surgical procedures that modify the upper gastrointestinal tract anatomy (RYBP and SG) are more successful in producing weight loss and remission of T2D than those that simply restrict stomach capacity (LAGB). Younger age, short duration of diabetes and better glucose control confer higher probability of achieving remission of diabetes.
Similar content being viewed by others
References
Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ (2013) Bariatric surgery versus non surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. BMJ 347:f5934
Sjöström L, Lindroos AK, Peltonen M, Torgerson J et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693
Sjöström L, Peltonen M, Jacobson P et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65
Sjöström L, Narbro K, Sjöström CD, Karaso K, Larsson B, Wedel H et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752
Bonora E (2006) The metabolic syndrome and cardiovascular disease. Ann Med 38:64–80
Colagiuri S (2010) Diabesity: therapeutic options. Diabetes Obes Metab 12:463–473
Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwa JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366:1567–1576
Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366:1577–1585
Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP (2013) Roux-en-Y gastric bypass versus intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA 309:2240–2249
Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X (2013) Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract 101:50–56
Brethauer SA, Aminian A, Romer-Talamas H et al (2013) Can diabetes be surgically cured? Ann Surg 258:628–637
Adams ST, Salhab M, Hussain ZI, Miller GV, Leveson SH (2013) Preoperatively determinable factors predictive of diabetes mellitus remission following Roux-en-Y gastric bypass: a review of the literature. Acta Diabetol 50:475–478
Moghissi ES, Korytkowski MT, DiNardo M et al (2009) American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32:1119–1131
Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL 2nd, Robertson RP, Rubino F, Kahn R, Kirkman MS (2009) How do we define cure of diabetes? Diabetes Care 32:2133–2135
Kim D, Kim KJ, Huh JH, Lee BW, Kang ES, Cha BS, Lee HC (2012) The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function. Clin Endocrinol 77:679–683
Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19
Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256
Pok EH, Lee WJ (2014) Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus. World J Gastroenterol 20:14315–14328
Wang GF, Yan YX, Xu N, Yin D, Hui Y, Zhang JP, Han GJ, Ma N, Wu Y, Xu JZ, Yang T (2015) Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg 25:199–208
Li C, Yang H, Tong G, Shen S, Feng W, Bi Y, Zhu D (2014) Correlations between A1c, fasting glucose, 2 h postload glucose, and βcell function in the Chinese population. Acta Diabetol 51:601–608
Funakoshi S, Fujimoto S, Hamasaki A, Fujiwara H, Fujita Y, Ikeda K, Hamamoto Y, Hosokawa M, Seino Y, Inagaki N (2008) Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract 82:353–358
Campos GM, Rabl C, Roll GR, Peeva S, Prado Kris, Smith J, Vittinghoff E (2011) Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass versus banding results of a two-cohort pair-matched study. Arch Surg 146:149–155
Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH (2014) Long-term follow-up after bariatric surgery. Syst Rev JAMA 312:934–942
Pham S, Gancel A, Scotte M, Houivet E, Huet E, Lefebvre H, Khun JM, Prevost G (2014) Comparison of the effectiveness of four bariatric surgery procedures in obese patients with type 2 diabetes: a retrospective study. J Obes. doi:10.1155/2014/638203 Epub 2014 May
Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N (2010) Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass and adjustable gastric banding on type 2 diabetes. Surg Endosc 24:1005–1010
Erqou S, Lee CC, Adler AI (2014) Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis. Diabetologia 57:2444–2452
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard
The study has been reviewed by the Ethic Committee of the University of Verona, and has been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Managed by Massimo Federici.
Rights and permissions
About this article
Cite this article
Zenti, M.G., Rubbo, I., Ceradini, G. et al. Clinical factors that predict remission of diabetes after different bariatric surgical procedures: interdisciplinary group of bariatric surgery of Verona (G.I.C.O.V.). Acta Diabetol 52, 937–942 (2015). https://doi.org/10.1007/s00592-015-0738-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-015-0738-8